Search

Your search keyword '"Solé, Guilhem"' showing total 271 results

Search Constraints

Start Over You searched for: Author "Solé, Guilhem" Remove constraint Author: "Solé, Guilhem"
271 results on '"Solé, Guilhem"'

Search Results

2. Phenotype variability and natural history of X-linked myopathy with excessive autophagy

4. Transthyretin amyloid cardiomyopathy in France: A cross-sectional multi-centre study (333 patients)

6. Multidisciplinary team meetings in treatment of spinal muscular atrophy adult patients: a real-life observatory for innovative treatments

7. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

8. Peripheral neuropathy and livedoid vasculopathy

9. Neurologic manifestations of giant cell arteritis

10. Dystrophies musculaires des ceintures associées aux mutations de TRIM32 : cohorte française et revue de la littérature

11. Convergence of patient- and physician-reported outcomes in the French National Registry of Facioscapulohumeral Dystrophy

14. Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

17. Titin copy number variations associated with dominant inherited phenotypes.

18. A multicenter cross-sectional French study of the impact of COVID-19 on neuromuscular diseases

19. Titin copy number variations associated with dominant inherited phenotypes

21. LRSAM1 variants and founder effect in French families with ataxic form of Charcot-Marie-Tooth type 2

24. Clinical Neurology in Practice

26. Myopathy and scleromyxedema

28. Characterization of novel CACNA1A splice variants by RNA‐sequencing in patients with episodic or congenital ataxia

29. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

30. Titin copy number variations associated with dominant inherited phenotypes

31. Papilledema and Peripheral Neuropathies

32. À propos de 12 cas d’intoxication au protoxyde d’azote diagnostiqués au CHU de Bordeaux en 2021 : nécessité du dosage de l’homocystéine totale plasmatique, biomarqueur de la carence cellulaire en vitamine B12

37. Otopalatodigital spectrum disorders: refinement of the phenotypic and mutational spectrum

38. Macroglossia: A potentially severe complication of late‐onset Pompe disease

39. Renal involvement is frequent in adults with primary mitochondrial disorders: an observational study.

42. Identification of Serum Interleukin 6 Levels as a Disease Severity Biomarker in Facioscapulohumeral Muscular Dystrophy

44. Deep phenotyping of an international series of patients with late‐onset dysferlinopathy

46. An Integrated Clinical-Biological Approach to Identify Interindividual Variability and Atypical Phenotype-Genotype Correlations in Myopathies: Experience on A Cohort of 156 Families

47. Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia Gravis

49. Motor and respiratory decline in patients with late onset Pompe disease after cessation of enzyme replacement therapy during COVID‐19 pandemic.

50. The lncRNA 44s2 Study Applicability to the Design of 45-55 Exon Skipping Therapeutic Strategy for DMD

Catalog

Books, media, physical & digital resources